10.1002/chem.201704443
Chemistry - A European Journal
FULL PAPER
was obtained as a pale-yellow oil, Rf 0.37. Yield 79 mg (0.229 mmol,
92%), dr >98:2, er 96:4. 1H NMR (500 MHz, CDCl3): δ 7.33 – 7.23 (m,
4H), 7.21 – 7.13 (m, 1H), 3.50 – 3.29 (m, 2H), 3.27 – 3.14 (m, 2H), 1.65
(dd, J = 9.8, 3.9 Hz, 1H), 1.41 (dd, J = 7.5, 3.9 Hz, 1H), 1.24 (s, 6H), 1.22
(s, 6H), 1.16 (t, J = 7.1 Hz, 3H), 0.71 (t, J = 7.1 Hz, 3H), 0.65 (dd, J = 9.8,
7.5 Hz, 1H); 13C (126 MHz, CDCl3): δ 175.5, 140.1, 128.7 (+, 2C), 127.7
(+, 2C), 126.8 (+), 81.4 (2C), 43.1 (-), 42.1 (-), 36.0, 25.2 (+, 2C), 25.1 (+,
2C), 19.5 (-), 18.7, 12.6 (+), 12.6 (+); FT IR (KBr, cm-1): 3061, 2976,
2935, 2876, 1643, 1634, 1601, 1470, 1454, 1404, 1381, 1325, 1211,
1142, 1115, 953, 860, 760, 700; HRMS (TOF ES): HRMS (TOF ES):
Found 366.2214, calculated for C20H30BNO3Na (M+Na) 366.2216 (0.5
ppm); [α]D20 +43.2o (c 1.13, CH2Cl2).
ES): Found 338.2650, calculated for C22H33BNO (M+H) 338.2655 (1.5
ppm).
(1-(2,4-Difluorophenyl)cyclopropyl)methanol (23j): This compound
was obtained via under condition of typical procedure B employing (1-
(2,4-difluorophenyl)cycloprop-2-en-1-yl)methanol (22j)[30] (91.0 mg, 0.50
mmol, 1.00 equiv.). The product was purified by column chromatography
eluting with a mixture hexane:EtOAc (3:1). The titled compound was
obtained as a pale yellow oil, Rf 0.22. Yield 45.1 mg (0.244 mmol, 49%).
1H NMR (500 MHz, CDCl3): δ 7.34 – 7.27 (m, 1H), 6.90 – 6.73 (m, 2H),
3.60 (d, J = 6.1 Hz, 2H), 1.47 (t, J = 6.2 Hz, 1H), 0.92 – 0.76 (m, 4H); 13C
NMR (126 MHz, CDCl3): δ 162.6 (dd, J = 249.5, 11.8 Hz), 162.1 (dd, J =
247.7, 12.0 Hz), 133.2 (+, dd, J = 9.6, 6.0 Hz), 125.6 (dd, J = 14.1, 3.7
Hz), 111.1 (+, dd, J = 20.9, 3.6 Hz), 105.5 – 101.5 (+, m), 70.4 (-), 23.6,
10.3 (-, d, J = 1.7 Hz, 2C); 19F NMR (376 MHz, CDCl3) δ -111.5 (d, J =
7.5 Hz), -112.0 (d, J = 7.5 Hz); FT IR (KBr, cm-1): 3354, 3082, 3007,
2928, 2872, 1614, 1601, 1506, 1466, 1421, 1267, 1138, 1117, 1084,
1036, 968, 849, 816, 734; HRMS (TOF ES): HRMS (TOF ES): Found
235.0558, calculated for C11H10F2O2Na (M+Na) 235.0547 (4.7 ppm).
The same reaction was performed in the presence of cationic Rh species.
To this end (procedure C), the reaction vessel was charged [Rh(CO)Cl]2
(6.1 mg, 12 μmol, 4 mol%), AgOTf (6.6 mg, 26 μmol, 8.5 mol%), and (R)-
BINAP (15 mg, 24 μmol, 8.0 mol%). Anhydrous THF was added and the
mixture was stirred at room temperature for 30 min. Then pinacolborane
(76 mg, 0.30 mmol, 1.0 equiv.) was added, immediately followed with
N,N-diethyl-1-phenylcycloprop-2-ene-1-carboxamide (6a) (65 mg, 0.30
mmol, 1.0 equiv.). Alternatively (procedure D) the reaction vessel was
loaded with Bis(norbornadiene)rhodium(I) tetrafluoroborate (Rh(nbd)BF4,
9.0 mg, 24 μmol, 8.0 mol%), and (R)-BINAP (15 mg, 24 μmol, 8.0 mol%).
Anhydrous THF was added and the mixture was stirred at room
temperature for 30 min. Then pinacolborane (76 mg, 0.30 mmol, 1.0
equiv.) was added, immediately followed with N,N-diethyl-1-
phenylcycloprop-2-ene-1-carboxamide (6a) (65 mg, 0.30 mmol, 1.0
equiv.). The resulting reaction mixtures were stirred at room temper-
ature for 18 hr and then worked up in the same manner as described
above for procedures A and B. In both cases compound 7a was
obtained as sole product as pale-yellow oil. Yields 99 mg (0.288 mmol,
96%), dr >98:2, er 95:5 for procedure C and 95 mg (0.276 mmol, 92%),
dr >98:2, er 95:5, for procedure D, respectively. Chromatographic and
spectral properties of these samples were identical to those for material
7a described above.
(+)-2-((1R,2S)-2-((Methoxymethoxy)methyl)-2-phenylcyclopropyl)-
4,4,5,5-tetramethyl-1,3,2-dioxaborolane (27a): This compound was
obtained via typical procedure B employing (1-((methoxymethoxy)meth-
yl)cycloprop-2-en-1-yl)benzene (24a)[11a] (95.2 mg, 0.50 mmol, 1.0
equiv.), [Rh(COD)Cl]2 (14.8 mg, 0.03 μmol, 0.06 equiv.) and (R)-BINAP
(37.4 mg, 0.06 mmol, 0.12 equiv.), pinacol borane (148.0 μl, 1.0 mmol,
2.0 equiv.) and allowing reaction to stir overnight. The product was
purified by column chromatography eluting with a mixture hexane:EtOAc
(20:1). The titled compound was obtained as a colorless oil, Rf 0.31.
Yield 128.2 mg (0.402 mmol, 81%), dr: 98:2, er: 68:32 (Column IC, IPA
3%, Flow rate 1 mL/min). 1H NMR (500 MHz, CDCl3) δ 7.43 – 7.38 (m,
2H), 7.31 – 7.25 (m, 2H), 7.21 – 7.16 (m, 1H), 4.53 (s, 2H), 3.96 (d, J =
10.1 Hz, 1H), 3.70 (d, J = 10.1 Hz, 1H), 3.14 (s, 3H), 1.29 (s, 6H), 1.28 (s,
6H), 1.22 (dd, J = 9.5, 3.8 Hz, 1H), 1.12 (dd, J = 7.3, 3.8 Hz, 1H), 0.47
(dd, J = 9.5, 7.3 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 144.7, 128.9 (+,
2C), 128.1 (+, 2C), 126.3 (+), 96.3 (-), 83.4 (2C), 72.8 (-), 55.1 (+), 32.3,
25.1 (+, 2C), 24.8 (+, 2C), 17.6 (-), 7.3 (+); FT IR (KBr, cm-1): 2978, 2929,
2882, 1415, 1371, 1323, 1215, 1147, 1106, 1053, 966, 859, 700; HRMS
(TOF ES): Found 337.2322, calculated for C20H31BO2Na (M+Na)
337.2315 (2.1 ppm); [α]D20 +10.5o (c 1.04, CHCl3).
Hydroboration of Other Substrates
2-(9-Borabicyclo[3.3.1]nonan-9-yl)-N,N-diethyl-1-phenylcycloprop-
ane-1-carboxamide (20): This compound was obtained via typical
procedure B using N,N-diethyl-1-phenylcycloprop-2-ene-1-carboxamide
(6a) (108 mg, 0.50 mmol, 1.0 equiv.) and 9-borabicyclo[3.3.1]nonane
dimer (1.0 ml, 0.5M in THF, 0.50 mmol, 1.0 equiv.) and allowing reaction
to stir overnight. The product was purified by column chromatography
eluting with a mixture hexane:EtOAc (3:1). The titled compound was
obtained as a colorless solid, Rf 0.31. Yield 89.6 mg yield (0.266 mmol,
53%), dr: 70:30. 1H NMR (500 MHz, CDCl3): Major (trans): δ 7.32 – 7.27
(m, 2H), 7.26 – 7.18 (m, 3H), 3.48 (dq, J = 14.2, 7.1 Hz, 1H), 3.35 (dq, J
= 14.0, 7.1 Hz, 1H), 3.26 (dq, J = 14.4, 7.2 Hz, 1H), 3.07 (dq, J = 14.2,
7.1 Hz, 1H), 1.99 – 1.88 (m, 2H), 1.86 – 1.80 (m, 3H), 1.76 – 1.66 (m,
5H), 1.54 (s, 2H), 1.46 – 1.40 (m, 1H), 1.21 (t, J = 7.1 Hz, 3H), 1.00 –
0.93 (m, 2H), 0.73 (t, J = 7.1 Hz, 3H), 0.69 – 0.64 (m, 1H), 0.50 – 0.42 (m,
1H). Minor (cis): δ 7.31 – 7.27 (m, 2H), 7.21 – 7.17 (m, 2H), 7.11 – 7.06
(m, 1H), 3.74 – 3.38 (m, 4H), 1.95 (dd, J = 8.4, 2.8 Hz, 1H), 1.92 – 1.82
(m, 3H), 1.82 – 1.73 (m, 1H), 1.71 – 1.61 (m, 3H), 1.54 (s, 2H), 1.45 (dd,
J = 8.4, 2.7 Hz, 1H), 1.34 (t, J = 7.2 Hz, 3H), 1.26 – 1.23 (m, 1H), 1.25 (t,
J = 7.2 Hz, 3H), 1.22 – 1.16 (m, 1H), 1.13 – 1.05 (m, 1H), 0.77 – 0.71 (m,
1H), 0.71 – 0.61 (m, 1H), 0.59 – 0.53 (m, 1H); 13C NMR (126 MHz,
CDCl3): Major (trans): δ 179.8, 140.8, 129.0 (+, 2C), 128.9 (+, 2C), 126.7
(+), 44.4 (-), 43.7 (-), 36.1, 33.6 (-), 32.7 (-), 32.4 (-), 31.8 (-), 28.0 (+),
27.9 (+), 25.9 (-), 25.5 (-), 18.8 (-), 12.6 (+), 12.5(+), 12.2 (+). Minor (cis):
δ 178.9, 148.3, 129.8 (+, 2C), 127.8 (+, 2C), 124.8 (+), 44.8 (-), 43.0 (-),
33.0 (-), 32.7 (-), 32.5 (-), 31.0 (-), 27.1, 27.0 (+), 26.9 (+), 25.6 (-), 25.0
(-), 21.5 (-), 14.3 (+), 13.0 (+), 12.9 (+); FT IR (KBr, cm-1): 2978, 2914,
2869, 2835, 1600, 1488, 1314, 1212, 968, 759, 726, 700; HRMS (TOF
(-)-(1S,2R)-1-Phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
cyclopropyl)methyl acetate (28a): This compound was obtained via
typical procedure B employing (1-phenylcycloprop-2-en-1-yl)methyl acet-
ate (25a)[11a] (94.2 mg, 0.50 mmol, 1.00 equiv.) and allowing the reaction
to stir overnight. The product was purified by column chromatography
eluting with a mixture hexane:EtOAc (3:1). The titled compound was
obtained as a pale-yellow oil, Rf 0.29. Yield 130.0 mg (0.412 mmol, 83%),
dr 96:4, er 79:21 (Column IC, IPA 3%, Flow Rate 1.0mL/min). 1H NMR
(500 MHz, CDCl3): δ 7.37 – 7.32 (m, 2H), 7.30 – 7.24 (m, 2H), 7.22 –
7.17 (m, 1H), 4.51 (d, J = 11.41 Hz, 1H), 4.19 (d, J = 11.4 Hz, 1H), 1.97
(s, 3H), 1.27 (s, 6H), 1.24 (s, 6H), 1.24 – 1.19 (m, 1H), 1.15 (dd, J = 7.3,
3.9 Hz, 1H), 0.51 (dd, J = 9.6, 7.3 Hz, 1H); 13C NMR (126 MHz, CDCl3):
δ 171.1, 143.8, 129.0 (+, 2C), 128.2 (+, 2C), 126.7 (+), 83.5 (2C), 70.2 (-),
31.1, 25.1 (+, 2C), 24.6 (+, 2C), 21.2 (+), 17.9 (-), 7.3; FT IR (KBr, cm-1):
3059, 2978, 2934, 1742, 1732, 1416, 1371, 1362, 1327, 1248, 1215,
1167, 1144, 1028, 976, 858, 729, 700, 671; HRMS (TOF ES): HRMS
(TOF ES): Found 339.1745, calculated for C18H25BO4Na (M+Na)
339.1744 (0.3 ppm); [α]D20 -35.6o (c 1.25, CHCl3).
(-)-tert-Butyldimethyl(((1S,2R)-1-phenyl-2-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)cyclopropyl)methoxy)silane (29a): This compound
was obtained via typical procedure B employing tert-butyldimethyl((1-
phenylcycloprop-2-en-1-yl)methoxy)silane (26a) (130.2 mg, 0.50 mmol,
8
This article is protected by copyright. All rights reserved.